| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) | 
|---|
| 03/23/2011 | EP2299275A2 Classification of the oncofetal fibronection level for the indication of diseases and other conditions | 
| 03/23/2011 | EP2299274A1 SCD fingerprints | 
| 03/23/2011 | EP2299273A1 Method of assaying physiologically active substance of biological origin, kit for assaying physiologically active substance of biological origin and apparatus for assaying physiologically active substance of biological origin | 
| 03/23/2011 | EP2299272A2 N-terminally truncated HER-2/NEU protein as a cancerprognostic indicator | 
| 03/23/2011 | EP2299271A2 Kokumi-imparting agent | 
| 03/23/2011 | EP2299270A1 Method for stabilizing microparticles having reactive substance bound thereto, and reagent containing the microparticles | 
| 03/23/2011 | EP2299269A1 Protein fragment complementation assay based on beta-lactamase | 
| 03/23/2011 | EP2299268A2 Methods and compositions for diagnosing hepatocellular carcinoma | 
| 03/23/2011 | EP2299267A2 Biomarkers for anti-NogoA antibody treatment in spinal cord injury | 
| 03/23/2011 | EP2299266A1 Methods and materials for assessing prostate cancer therapies | 
| 03/23/2011 | EP2299265A1 Cancer eradication program | 
| 03/23/2011 | EP2299264A2 Device for measuring a gas content in a gas mixture | 
| 03/23/2011 | EP2299259A1 Method and Apparatus for In-Vitro-Analysis of Biological Cells and/or Microorganisms | 
| 03/23/2011 | EP2299257A2 Device and method for detecting molecular interactions | 
| 03/23/2011 | EP2299256A2 Microfabricated crossflow devices and methods | 
| 03/23/2011 | EP2299255A2 Tear film osmometry | 
| 03/23/2011 | EP2298968A2 Method for growing nanowires | 
| 03/23/2011 | EP2298936A1 Genomic fingerprint of mammary cancer | 
| 03/23/2011 | EP2298931A1 Apparatus for performing PCT and monitoring the reaction in real time during temperature cycling | 
| 03/23/2011 | EP2298929A1 Sorting and immobilization system for nucleic acids using synthetic binding systems | 
| 03/23/2011 | EP2298902A1 Luciferase biosensor | 
| 03/23/2011 | EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor | 
| 03/23/2011 | EP2298884A1 Method for detection of thermotolerant bacterium | 
| 03/23/2011 | EP2298878A2 Compositions and methods for the diagnosis of cancer | 
| 03/23/2011 | EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them | 
| 03/23/2011 | EP2298814A2 Method for quantifying phosphokinase activity on proteins | 
| 03/23/2011 | EP2298809A2 Super humanized antibodies | 
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses | 
| 03/23/2011 | EP2298806A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof | 
| 03/23/2011 | EP2298804A2 Monoclonal antibody production by EBV transformation of B cells | 
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof | 
| 03/23/2011 | EP2298802A1 T1R3 taste receptors and genes encoding same | 
| 03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits | 
| 03/23/2011 | EP2298792A2 Peptides targeted to protein kinase C isoforms and uses thereof | 
| 03/23/2011 | EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins | 
| 03/23/2011 | EP2298519A1 Device for controlling the quality of the production process of concrete products | 
| 03/23/2011 | EP2298449A2 Analytical device | 
| 03/23/2011 | EP2298379A1 Systems for detecting patient access disconnection | 
| 03/23/2011 | EP2298361A2 Ocular diagnosis of Alzheimer's disease | 
| 03/23/2011 | EP2298342A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto | 
| 03/23/2011 | EP2298334A2 Tweak receptor | 
| 03/23/2011 | EP2298333A2 Tweak receptor | 
| 03/23/2011 | EP2298304A2 Carboline derivatives useful in the treatment of cancer | 
| 03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) | 
| 03/23/2011 | EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | 
| 03/23/2011 | EP2298231A2 Apparatus and methods for providing sex-sorted animal sperm | 
| 03/23/2011 | EP2298170A1 Test device for analyzing body fluids | 
| 03/23/2011 | EP2297585A1 Detection of cannabis use | 
| 03/23/2011 | EP2297584A1 High throughput method for analyzing the fatty acid composition in plasma phosphoglycerides | 
| 03/23/2011 | EP2297583A2 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides | 
| 03/23/2011 | EP2297582A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof. | 
| 03/23/2011 | EP2297581A1 Asc as a marker for lung cancer | 
| 03/23/2011 | EP2297580A2 Protein | 
| 03/23/2011 | EP2297579A1 Determination of distribution | 
| 03/23/2011 | EP2297578A2 Vaccine assays | 
| 03/23/2011 | EP2297577A1 Methods and systems for increasing protein food safety | 
| 03/23/2011 | EP2297576A1 Established human brown adipocyte line and method for differentiation from an hmads cell line | 
| 03/23/2011 | EP2297575A1 MEANS AND METHODS FOR IDENTIFYING A SUBJECT BEING SUSCEPTIBLE TO A CARDIAC THERAPY BASED ON DETERMINATION OF A CARDIAC TROPONIN, sCD40L AND C-REACTIVE PROTEIN | 
| 03/23/2011 | EP2297574A1 Bio-sensor | 
| 03/23/2011 | EP2297573A1 Assay device | 
| 03/23/2011 | EP2297572A2 Multi-dimensional fluid sensors and related detectors and methods | 
| 03/23/2011 | EP2297349A1 Diffuse large b-cell lymphoma markers and uses therefor | 
| 03/23/2011 | EP2297345A1 Biomarkers for the identification, monitoring, and treatment of head and neck cancer | 
| 03/23/2011 | EP2297342A1 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea | 
| 03/23/2011 | EP2297341A1 Methods and compositions for the treatment of huntington's disease | 
| 03/23/2011 | EP2297335A1 Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling | 
| 03/23/2011 | EP2297334A1 Biomarker for assessing response to chymase treatment | 
| 03/23/2011 | EP2297333A1 Compositions and methods for spatial separation and screening of cells | 
| 03/23/2011 | EP2297332A2 Methods and platforms for drug discovery | 
| 03/23/2011 | EP2297325A1 Methods of stratifying, prognosing and diagnosing schizophrenia, mutant nucleic acid molecules and polypeptides | 
| 03/23/2011 | EP2297305A2 Isolation of stem cell precursors and expansion in non-adherent conditions | 
| 03/23/2011 | EP2297201A1 Antibody specific for propionylated/butyrylated lysine, method for obtaining same and uses thereof | 
| 03/23/2011 | EP2297196A1 Vaccine against amyloid folding intermediate | 
| 03/23/2011 | EP2296814A1 Microfluidic selection of library elements | 
| 03/23/2011 | EP2296812A1 Triple function electrodes | 
| 03/23/2011 | EP2296638A2 Identification of a molecular signature for antipsychotics and serms | 
| 03/23/2011 | EP2296478A1 Brown adipocyte progenitors in human skeletal muscle | 
| 03/23/2011 | EP1987357B8 Polypeptides recognized by anti-trichinella antibodies, and uses thereof | 
| 03/23/2011 | EP1950565B1 Method of assaying antigen | 
| 03/23/2011 | EP1910799B1 Apparatus and method for detecting an analyte | 
| 03/23/2011 | EP1870710B1 Biomarker for diagnosing heart disease and the use thereof | 
| 03/23/2011 | EP1853921B1 Detection of a therapeutic antibody in an experimental animal | 
| 03/23/2011 | EP1812586B1 Method for testing a compound for a therapeutic effect | 
| 03/23/2011 | EP1747465B1 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples | 
| 03/23/2011 | EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells | 
| 03/23/2011 | EP1501553B1 Cell growth, induction and lysis in an antibody-coated microplate for use in an elisa | 
| 03/23/2011 | EP1478753B1 Flavenoid methyltransferase from torenia and uses therefor | 
| 03/23/2011 | EP1478623B1 Novel coupling agents, the active intermediates and the conjugates thereof and the use of said conjugates in diagnostic methods | 
| 03/23/2011 | EP1469878B1 Fgfr agonists | 
| 03/23/2011 | EP1437966B1 Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water | 
| 03/23/2011 | EP1415150B1 Method for quantitative monitoring of a gas injected into a reservoir in particular in a natural environment | 
| 03/23/2011 | EP1410011B1 Diagnosis and prognosis of breast cancer patients | 
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays | 
| 03/23/2011 | EP1272503B1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i | 
| 03/23/2011 | EP1087960B1 Macrocyclic analogs and methods of their use and preparation | 
| 03/23/2011 | CN201774600U Video player with alcohol content measurement function | 
| 03/23/2011 | CN201773336U Device integrating temperature sensor and humidity sensor | 
| 03/23/2011 | CN201773105U Combined detection card for a plurality of heavy metals | 
| 03/23/2011 | CN201773104U Detecting card for detecting various heavy metals | 
| 03/23/2011 | CN201773103U Comprehensive postoperative infection prediction unit for children |